A carregar...
Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance
BACKGROUND: Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are an established treatment for patients with type 2 diabetes (T2D). Differences between GLP‐1RAs in pharmacokinetics, dosing regimens and clinical effects, including cardiovascular (CV) outcomes, mean there may be benefits to switchi...
Na minha lista:
| Publicado no: | Int J Clin Pract |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7900946/ https://ncbi.nlm.nih.gov/pubmed/32975890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.13731 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|